A Clinical Trial Assessing the Safety and Effectiveness of the DurAVR® THV System

NANot yet recruitingINTERVENTIONAL

Enrollment

1,650

Participants

Timeline

Start Date

October 31, 2025

Primary Completion Date

September 30, 2027

Study Completion Date

December 31, 2037

Conditions

Severe Aortic StenosisValve-in-valve Procedures

Interventions

DEVICE

TAVR with DurAVR® THV

Transcatheter aortic valve replacement (TAVR)

DEVICE

TAVR with SAPIEN THV series or the Evolut THV series

Transcatheter aortic valve replacement (TAVR)